July 14, 2025
By Staff Writer
July 11, 2025
July 10, 2025
Search By Category
July 14, 2025
By Staff Writer
July 11, 2025
July 14, 2025
By Staff Writer
July 11, 2025
July 10, 2025
July 8, 2025
🌟 Is talquetamab the game-changer in treating relapsed and refractory multiple myeloma?
This emerging therapy is paving the way for improved access and options in the Dutch healthcare system, as it moves towards inclusion in the basic health insurance package. Learn about its efficacy, safety, and the implications for health economics and policy.
Jump into the latest insights and recommendations in myeloma treatment!
#SyenzaNews #HealthcareInnovation #HealthEconomics
🚨 Publication delays are derailing academic careers!
In an insightful piece, “Dear editors, your publication delays are damaging our careers,” Chia-Hsuan Hsu reveals how prolonged editorial and peer-review processes are stifling early-career researchers, particularly in East Asia. With a focus on the systemic inefficiencies in academic publishing, the article discusses the urgent need for reform to protect researchers from the detrimental impacts of such delays.
Jump into the full article to uncover the challenges faced and explore proactive solutions for a more efficient publishing landscape. 📚✨
#SyenzaNews #HealthEconomics #HealthcarePolicy
🌍 What if a twice-yearly injectable could transform HIV prevention in low-income regions?
Gilead’s new partnership with the Global Fund aims to provide lenacapavir—an innovative injectable for HIV prevention—at no profit, reaching up to two million individuals in low- and lower-middle-income countries. This groundbreaking initiative not only addresses critical access barriers but also sets a precedent for how public-private partnerships can enhance health equity.
Dive into the details of this pivotal collaboration and its implications for global health.
#SyenzaNews #globalhealth #HealthcareInnovation
SPEAK WITH US
CORRESPONDENCE ADDRESS
1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA
WRITE US
JOIN NEWSLETTER